Get all your news in one place.
100's of premium titles.
One app.
Start reading
StockNews.com
StockNews.com
Business
Aanchal Sugandh

HISTORICAL FACTS: Top 3 stocks to sell in april with weak fundamentals - The Untold Story

Rising interest rates and recent turmoil in the banking sector seem to be affecting the biopharmaceutical industry as it heavily relies on consistent funding for R&D. Furthermore, several regulatory and structural obstacles are hampering the industry’s growth.

Given industry-wide and macroeconomic headwinds, investors should steer clear of fundamentally weak biopharmaceutical stocks Syndax Pharmaceuticals, Inc. (SNDX), Senseonics Holdings, Inc. (SENS), and Sio Gene Therapies Inc. (SIOX). Let’s discuss this in detail.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.